Association between the Use of Fondaparinux Plus Radial Access and Clinical Outcomes in Patients with Non-ST

Luiz Eduardo Fonteles Ritt1,2, Eduardo Sahade Darze1,2, Pedro Gabriel Melo de Barros E Silva3

  • 1Instituto D'Or de Pesquisa e Ensino, Hospital Cardio Pulmonar, BA - Brasil.

PubMed

Insights

Combining fondaparinux and radial access significantly lowers major adverse cardiovascular events (MACE) and bleeding in acute coronary syndrome (ACS) patients. This strategy offers superior outcomes compared to other anticoagulation and access site combinations.

Area of Science:

  • Cardiology
  • Clinical Trials
  • Pharmacology

Background:

  • Fondaparinux and radial access are individually linked to reduced major adverse cardiovascular events (MACE) in acute coronary syndrome (ACS).
  • Investigating the combined effect of these strategies is crucial for optimizing patient care in ACS.

Purpose of the Study:

  • To evaluate the combined impact of fondaparinux and radial access on clinical outcomes in ACS patients.
  • To compare the efficacy and safety of fondaparinux plus radial access against other anticoagulation and arterial access combinations.

Main Methods:

  • Analysis of 956 ACS patients undergoing invasive procedures.
  • Primary outcome: composite of major bleeding (OASIS-5 criteria) and MACE.
  • Comparison across four groups: fondaparinux/enoxaparin with femoral/radial access.

Main Results:

  • The combination of fondaparinux and radial access demonstrated the lowest event rate (3.3%).
  • Fondaparinux use was associated with a 43% reduction in the primary outcome (OR, 0.57; p < 0.05).
  • Radial access independently reduced the primary outcome by 54% (OR, 0.46; p = 0.01).

Conclusions:

  • The concurrent use of fondaparinux and radial access is associated with the lowest rates of MACE and major bleeding in ACS.
  • This combination strategy appears superior to using either fondaparinux or radial access alone, or in combination with enoxaparin or femoral access, respectively.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
197
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.0K
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
221
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
262
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
354